Sort
78,016 grants matching “breast cancer”
Enhancing cancer outreach for low-income adults with innovative smoking cessation
$654,393Alexander V Prokhorov · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
AMPLIFICATION OF JAK2 IN BREAST CANCER: A MOLECULAR LESION THAT CAN BE EXPLOITED NOW
$654,352Vanderbilt University, The · · FY2014 · Department of the Army
Etiologic Heterogeneity Between Molecular Subtypes of Prostate Cancer
$654,340Konrad Hermann Stopsack · Massachusetts General Hospital · R37 · FY2024 · CA
BC12200 THERAPEUTIC MECHANISM OF BET BROMODOMAIN INHIBITOR IN BREAST CANCER
$654,320Dana-Farber Cancer Institute, Inc. · · FY2013 · Department of Defense
Early Life Conditions, Survival, and Health: A Pedigree-Based Population Study
$654,307Ken R Smith · University Of Utah · R01 · FY2015 · AG
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$654,307Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
$654,304Mary Anne Rossing · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
$654,245Jenny C-N Chang · Methodist Hospital Research Institute · R01 · FY2025 · CA
MicroRNA & Breast Cancer: Functional Characterization in a Population-Based Study
$654,243Jia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA
Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers
$654,233Jacek Capala · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Core 1
$654,206Ann G Schwartz · Wayne State University · P01 · FY2025 · CA
Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM)
$654,163Kathryn E Flynn · Medical College Of Wisconsin · R01 · FY2025 · CA
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
$654,143Allison W. Kurian · Stanford University · R01 · FY2025 · CA
Impact of enhancements to smartphone-based continuing care for alcohol dependence
$654,114James R McKay · University Of Pennsylvania · R01 · FY2016 · AA
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
$654,071Dawn Hershman · Columbia University Health Sciences · P50 · FY2024 · MD
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
$654,067Urmimala Sarkar · University Of California, San Francisco · R01 · FY2021 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$654,058Robert H Vonderheide · University Of Pennsylvania · P01 · FY2019 · CA
Optimizing Lung Cancer Screening in Cancer Survivors
$654,045Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
NOVEL ANTITUMOR DISULFIDES
$654,041Prolx Pharmaceuticals, Lp · R44 · FY2002 · CA
Towards screening with high-resolution, low-dose, dedicated breast CT
$654,022Srinivasan Vedantham · University Of Arizona · R01 · FY2025 · CA
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)
$653,945Mark E Sherman · Mayo Clinic Jacksonville · R01 · FY2023 · CA
Genomic Evolution of Breast Cancer
$653,942Arend Sidow · Stanford University · R01 · FY2017 · CA
Genomic Evolution of Breast Cancer
$653,942Arend Sidow · Stanford University · R01 · FY2018 · CA
Genomic Evolution of Breast Cancer
$653,942Arend Sidow · Stanford University · R01 · FY2015 · CA
DC City-wide Patient Navigation Research Program
$653,938George Washington University · U01 · FY2005 · CA